Can Vitamin D Reduce Inflammation? The Influence of Supplementation on Selected Immunological Markers
- PMID: 39062835
- PMCID: PMC11277077
- DOI: 10.3390/ijms25147592
Can Vitamin D Reduce Inflammation? The Influence of Supplementation on Selected Immunological Markers
Abstract
There is increasing evidence that vitamin D (VitD) supplementation may reduce inflammation in individuals with multiple sclerosis (MS). The aim of this study was to evaluate the effect of different doses of VitD on selected markers of inflammation in patients with relapsing-remitting MS (RRMS). Participants were divided depending on the supplemented dose of VitD into a high-dose (2000 IU/d; HD) group and a low-dose (15,960 IU/month; LD) group (n = 23 and n = 29, respectively). The concentration of 25(OH)D and the levels of CXCL16, PTX3, ALCAM, IL-1RA, and OPG were measured initially and after six months of VitD supplementation in blood serum. A significant increase in the concentrations of CXCL16, PTX3, and OPG was observed during the study (p = 0.02, p = 0.01, and p < 0.01, respectively). Furthermore, a higher increase in PTX3 and OPG in the LD group was observed (p = 0.04 and p = 0.03, respectively). A significant positive correlation was observed between the 25(OH)D serum concentration and PTX3 (R = 0.28, p < 0.05) and OPG (R = 0.28, p < 0.05) only at the beginning of the study. In patients with RRMS, such doses of VitD might be too low to induce obvious beneficial effects on the pro-inflammatory and inflammatory balance.
Keywords: immune system; inflammation; multiple sclerosis; supplementation; vitamin D.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.J Neurol. 2015 Dec;262(12):2713-21. doi: 10.1007/s00415-015-7902-5. Epub 2015 Oct 1. J Neurol. 2015. PMID: 26429571 Clinical Trial.
-
Can Vitamin D Supplementation Improve Inflammation in Relapsing-Remitting Multiple Sclerosis Patients?Biomedicines. 2024 Jul 17;12(7):1580. doi: 10.3390/biomedicines12071580. Biomedicines. 2024. PMID: 39062153 Free PMC article.
-
Vitamin D supplementation does not alter inflammatory markers in overweight and obese individuals: A systematic review and meta-analysis of randomized controlled trials.Nutr Res. 2024 Aug;128:24-37. doi: 10.1016/j.nutres.2024.06.005. Epub 2024 Jun 17. Nutr Res. 2024. PMID: 39002359
-
Reassessing vitamin D supplementation in preterm infants: a prospective study and review of the literature.J Pediatr Endocrinol Metab. 2020 Aug 31;33(10):1273-1281. doi: 10.1515/jpem-2020-0370. J Pediatr Endocrinol Metab. 2020. PMID: 32866125 Review.
-
A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.J Steroid Biochem Mol Biol. 2016 Nov;164:254-257. doi: 10.1016/j.jsbmb.2015.11.009. Epub 2015 Nov 17. J Steroid Biochem Mol Biol. 2016. PMID: 26598277 Review.
References
-
- Ortiz G.G., Pacheco-Moisés F.P., Bitzer-Quintero O.K., Ramírez-Anguiano A.C., Flores-Alvarado L.J., Ramírez-Ramírez V., Macias-Islas M.A., Torres-Sánchez E.D. Immunology and Oxidative Stress in Multiple Sclerosis: Clinical and Basic Approach. Clin. Dev. Immunol. 2013;2013:708659. doi: 10.1155/2013/708659. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous